Cite
HARVARD Citation
Stein, A. et al. (2015). Mode of action of maintenance immunotherapy therapy with the TLR-9 agonist MGN1703 in metastatic colorectal carcinoma: the Phase III IMPALA study. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].